Regeneron pauses dosing in phase II trial of garetosmab for fibrodysplasia ossificans progressiva Nov. 3, 2020
Crinetics presents phase II data from ACROBAT Edge and ACROBAT Evolve studies of paltusotine Oct. 27, 2020
Intellia receives authorization to initiate first-in-human study of NTLA-2001 in the U.K. Oct. 20, 2020
RSS